Careers

» biotech, publishing and pharma

Most Recent

image: Self Correction

Self Correction

By | December 1, 2015

What to do when you realize your publication is fatally flawed

0 Comments

image: Riding Out Rejection

Riding Out Rejection

By | March 1, 2015

How to navigate the choppy waters of scientific publication

9 Comments

image: Simultaneous Release

Simultaneous Release

By | June 1, 2014

Coordinating the submission of manuscripts can strike a healthy balance between competition and collaboration.

1 Comment

image: Preserving Research

Preserving Research

By | August 1, 2013

The top online archives for storing your unpublished findings

1 Comment

image: Start It Up

Start It Up

By | April 1, 2013

Young researchers who left the academic path to transform their bright ideas into thriving companies discuss their experiences, and how you can launch your own business.

1 Comment

image: The Best of Both Worlds

The Best of Both Worlds

By | April 1, 2012

Choosing to work in industry does not preclude a return to academe. But the move back takes some planning and finesse.

3 Comments

Female Frontrunners

By | February 1, 2012

How to successfully surmount the challenges women face in becoming biotech industry leaders

7 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech